Hiku Brands to acquire leading Quebec based cannabis brand Maïtri

Hiku Brands Company Ltd. (CSE: HIKU), Canada's first vertically-integrated cannabis brand house, is pleased to announce it has entered into a binding letter of intent to acquire 100% of the issued and outstanding shares of Maïtri Group Inc., a Quebec-based cannabis accessory and design brand. The proposed acquisition represents the first brand acquisition by Hiku.

Organigram Announces Closing of $115 Million Convertible Debenture Bought Deal Financing

Organigram Holdings Inc. (TSX VENTURE:OGI) (OTCQB:OGRMF), a leading licensed producer of medical marijuana based in Moncton, New Brunswick, is pleased to announce that it has closed its previously announced short form prospectus offering of convertible unsecured debentures of the Company, on a bought deal basis, including the full exercise of the over-allotment option.

MedReleaf Corp. Announces Closing of Previously Announced Offering

MedReleaf Corp. (TSX:LEAF) is pleased to announce that it has closed its previously announced offering, on a "bought deal" basis, pursuant to a short form prospectus, of an aggregate of 5,000,000 units of the Company at a price of $26.50 per Unit for aggregate gross proceeds to the Company of $132,500,000.

ABcann Global Corporation Announces $70 Million Bought Deal Financing

ABcann Global Corporation (TSXV:ABCN) announced today that it has entered into an agreement with Canaccord Genuity Corp. and Eight Capital, on their own behalf and on behalf of a syndicate of underwriters, pursuant to which the Underwriters will purchase, on a bought deal basis pursuant to the filing of a short form prospectus, an aggregate of: (i) 11,500,000 units of the Company at a price of $3.50 per Unit for aggregate gross proceeds of $40,250,000; and (ii) 30,000 unsecured convertible debentures of the Company at a price of $1,000 per Convertible Debenture for aggregate gross proceeds of $30,000,000.

Invictus MD Jumpstarts Revenue Stream With Sale of First 120 kg of Flower to Canopy Growth Corporation; Signs Definitive Agreement to Increase Ownership of AB Laboratories in Ontario from 33.3% to 50%

INVICTUS MD STRATEGIES CORP. (TSXV: IMH; OTC: IVITF; FRA: 8IS1) is pleased to announce the sale of its first 120 kg of dried flower from AB Laboratories Inc., the licensed production facility under the Access to Cannabis for Medical Purposes Regulations, near Hamilton to Canopy Growth Corporation (TSX:WEED)